Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement

NCT05053308 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The supply of IP is disrupted

Conditions

Cancer Pain
Breakthrough Pain

Interventions

DRUG: Intravenous Infusion
DRUG: Sublingual Tablet

Sponsor

Seoul National University